Evidence map›Paper›PMID 30766553›Full record

ArticleAfrican health sciences2018

Effects of gender, age and treatment duration on lipid profile and renal function indices in diabetic patients attending a teaching hospital in South-Western Nigeria.

Mary Alaba Aderibigbe, Tajudeen Olabisi Obafemi, Mary Tolulope Olaleye, Afolabi Clement Akinmoladun

Abstract read
In one paragraph

Article in African health sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mary Alaba AderibigbeDepartment of Biochemistry, School of Sciences, The Federal University of Technology, P.M.B. 704, Akure, Nigeria.
Tajudeen Olabisi ObafemiDepartment of Biochemistry, School of Sciences, The Federal University of Technology, P.M.B. 704, Akure, Nigeria.
Mary Tolulope OlaleyeDepartment of Biochemistry, School of Sciences, The Federal University of Technology, P.M.B. 704, Akure, Nigeria.
Afolabi Clement AkinmoladunDepartment of Biochemistry, School of Sciences, The Federal University of Technology, P.M.B. 704, Akure, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundType 2 Diabetes Mellitus (T2DM) is associated with diabetic nephropathy and hyperlipidemia. Gender, age, medication adherence, lifestyle, culture and socioeconomic status could be sources of diversity in T2DM leading to differences in predisposition, development and clinical presentation.

objectivesTherefore, this study aimed to investigate the influence of gender, age and treatment duration on kidney and lipid-related biochemical indices of T2DM patients attending Ekiti State University Teaching Hospital, Ado-Ekiti, Nigeria (EKSUTH).

methodsBlood from diabetic patients and healthy subjects was analysed for fasting blood glucose (FBG), renal function parameters and lipid profile. Influence of age, gender and treatment duration on indices was assessed using standard baseline values.

resultsDyslipidemia was pronounced among female diabetics while the incidence of diabetes was found to be higher in middle-age. The percentage of diabetics with high levels of FPG, urea, creatinine, cholesterol, triglyceride and low density lipoprotein-cholesterol after 9-10 years of treatment were lower compared with the percentage after 5-6 years of treatment.

conclusionGender, age and treatment duration influenced clinical course of T2DM among patients presenting at EKSUTH but long term treatment appeared to improve T2DM among patients.

Indexed as

AdultAgedAged, 80 and overAge FactorsBlood GlucoseBody Mass IndexCase-Control StudiesDiabetes Mellitus, Type 2DyslipidemiasFemaleHospitals, TeachingHumansHypoglycemic AgentsHypolipidemic AgentsKidney Function TestsLipidsBlood GlucoseHypoglycemic AgentsHypolipidemic AgentsLipidsatherogenic indexcreatininediabetesdyslipidemiaEkiti StateFasting blood glucose

Identifiers

PMID30766553
PMCPMC6354870

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.